Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1

  • Authors:
    • Jiaqi Xu
    • Takuya Sadahira
    • Rie Kinoshita
    • Shun‑Ai Li
    • Peng Huang
    • Koichiro Wada
    • Motoo Araki
    • Kazuhiko Ochiai
    • Hirofumi Noguchi
    • Masakiyo Sakaguchi
    • Yasutomo Nasu
    • Masami Watanabe
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Okayama University, Okayama 700‑8558, Japan, Cell Biology, Okayama University, Okayama 700‑8558, Japan, Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama 700‑8558, Japan, Department of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo 180‑0023, Japan, Department of Regenerative Medicine, University of The Ryukyus, Nishihara, Okinawa 903‑0213, Japan
  • Pages: 5638-5642
    |
    Published online on: August 28, 2017
       https://doi.org/10.3892/ol.2017.6833
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The third member of the Dickkopf family (DKK‑3), also known as reduced expression in immortalized cells (REIC), is a tumor suppressor present in a variety of tumor cells. Regarding the regulation of the Wnt/β‑catenin signaling pathway, exogenous DKK‑1 and DKK‑2 are reported to inhibit Wnt signaling by binding the associated effectors. However, whether exogenous DKK‑3 inhibits Wnt signaling remains unclear. A recombinant protein of human full‑length DKK‑3 was used to investigate the exogenous effects of the protein in vitro in KPK1 human renal cell carcinoma cells. It was demonstrated that the expression of phosphorylated (p‑)β‑catenin (inactive form as the transcriptional factor) was increased in KPK1 cells treated with the exogenous DKK‑3 protein. The levels of non‑p‑β‑catenin (activated form of β‑catenin) were consistently decreased. It was revealed that the expression of transcription factor (TCF) 1 and c‑Myc, the downstream transcription factors of the Wnt/β‑catenin signaling pathway, was inhibited following treatment with DKK‑3. A cancer cell viability assay confirmed the anti‑proliferative effects of exogenous DKK‑3 protein, which was consistent with a suppressed Wnt/β‑catenin signaling cascade. In addition, as low‑density lipoprotein receptor‑related protein 6 (LRP6) is a receptor of DKK‑1 and DKK‑2 and their interaction on the cell surface inhibits Wnt/β‑catenin signaling, it was examined whether the exogenous DKK‑3 protein affects LRP6‑mediated Wnt/β‑catenin signaling. The LRP6 gene was silenced and the effects of DKK‑3 on the time course of the upregulation of p‑β‑catenin expression were subsequently analyzed. Notably, LRP6 depletion elevated the base level of p‑β‑catenin; however, there was no significant effect on its upregulation course or expression pattern. These findings indicate that exogenous DKK‑3 upregulates p‑β‑catenin and inhibits Wnt/β‑catenin signaling in an LRP6‑independent manner. Therefore, exogenous DKK‑3 protein may inhibit the proliferation of KPK1 cells via inactivating Wnt/β‑catenin signaling.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Rini BI, Campbell SC and Escudier B: Renal cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Cadigan KM and Nusse R: Wnt signaling: A common theme in animal development. Genes Dev. 11:3286–3305. 1997. View Article : Google Scholar : PubMed/NCBI

5 

Cadigan KM and Liu YI: Wnt signaling: Complexity at the surface. J Cell Sci. 119:395–402. 2006. View Article : Google Scholar : PubMed/NCBI

6 

MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Tada M, Concha ML and Heisenberg CP: Non-canonical Wnt signalling and regulation of gastrulation movements. Semin Cell Dev Biol. 13:251–260. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Kohn AD and Moon RT: Wnt and calcium signaling: Beta-catenin-independent pathways. Cell Calcium. 38:439–446. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Niehrs C: Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene. 25:7469–7481. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Brott BK and Sokol SY: Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol. 22:6100–6110. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C and Niehrs C: Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 391:357–362. 1998. View Article : Google Scholar : PubMed/NCBI

12 

Fujii Y, Hoshino T and Kumon H: Molecular simulation analysis of the structure complex of C2 domains of DKK family members and β-propeller domains of LRP5/6: Explaining why DKK3 does not bind to LRP5/6. Acta Med Okayama. 68:63–78. 2014.PubMed/NCBI

13 

Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, et al: Functional and structural diversity of the human Dickkopf gene family. Gene. 238:301–313. 1999. View Article : Google Scholar : PubMed/NCBI

14 

Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A and Niehrs C: LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature. 411:321–325. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Naito S, Kanamori T, Hisano S, Tanaka K, Momose S and Kamata N: Human renal cell carcinoma: Establishment and characterization of two new cell lines. J Urol. 128:1117–1121. 1982. View Article : Google Scholar : PubMed/NCBI

16 

Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol. 34:657–663. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Sakaguchi M, Sadahira T, Ueki H, Kinoshita R, Murata H, Yamamoto KI, Futami J, Nasu Y, Ochiai K, Kumon H, et al: Robust cancer-specific gene expression by a novel cassette with hTERT and CMV promoter elements. Oncol Rep. Jun 12–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

18 

Abounader R, Ranganathan S, Kim BY, Nichols C and Laterra J: Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem. 76:1497–1508. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Morozov VM, Massoll NA, Vladimirova OV, Maul GG and Ishov AM: Regulation of c-met expression by transcription repressor Daxx. Oncogene. 27:2177–2186. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Mizobuchi Y, Matsuzaki K, Kuwayama K, Kitazato K, Mure H, Kageji T and Nagahiro S: REIC/Dkk-3 induces cell death in human malignant glioma. Neuro Oncol. 10:244–253. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Giles RH, van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 1653:1–24. 2003.PubMed/NCBI

22 

Nakamura RE and Hackam AS: Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors. 28:232–242. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Xu Q, Krause M, Samoylenko A and Vainio S: Wnt signaling in renal cell carcinoma. Cancers (Basel). 8:pii: E57. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Kinoshita R, Watanabe M, Huang P, Li SA, Sakaguchi M, Kumon H and Futami J: The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression. Oncol Rep. 33:2908–2914. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu J, Sadahira T, Kinoshita R, Li SA, Huang P, Wada K, Araki M, Ochiai K, Noguchi H, Sakaguchi M, Sakaguchi M, et al: Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1. Oncol Lett 14: 5638-5642, 2017.
APA
Xu, J., Sadahira, T., Kinoshita, R., Li, S., Huang, P., Wada, K. ... Watanabe, M. (2017). Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1. Oncology Letters, 14, 5638-5642. https://doi.org/10.3892/ol.2017.6833
MLA
Xu, J., Sadahira, T., Kinoshita, R., Li, S., Huang, P., Wada, K., Araki, M., Ochiai, K., Noguchi, H., Sakaguchi, M., Nasu, Y., Watanabe, M."Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1". Oncology Letters 14.5 (2017): 5638-5642.
Chicago
Xu, J., Sadahira, T., Kinoshita, R., Li, S., Huang, P., Wada, K., Araki, M., Ochiai, K., Noguchi, H., Sakaguchi, M., Nasu, Y., Watanabe, M."Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1". Oncology Letters 14, no. 5 (2017): 5638-5642. https://doi.org/10.3892/ol.2017.6833
Copy and paste a formatted citation
x
Spandidos Publications style
Xu J, Sadahira T, Kinoshita R, Li SA, Huang P, Wada K, Araki M, Ochiai K, Noguchi H, Sakaguchi M, Sakaguchi M, et al: Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1. Oncol Lett 14: 5638-5642, 2017.
APA
Xu, J., Sadahira, T., Kinoshita, R., Li, S., Huang, P., Wada, K. ... Watanabe, M. (2017). Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1. Oncology Letters, 14, 5638-5642. https://doi.org/10.3892/ol.2017.6833
MLA
Xu, J., Sadahira, T., Kinoshita, R., Li, S., Huang, P., Wada, K., Araki, M., Ochiai, K., Noguchi, H., Sakaguchi, M., Nasu, Y., Watanabe, M."Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1". Oncology Letters 14.5 (2017): 5638-5642.
Chicago
Xu, J., Sadahira, T., Kinoshita, R., Li, S., Huang, P., Wada, K., Araki, M., Ochiai, K., Noguchi, H., Sakaguchi, M., Nasu, Y., Watanabe, M."Exogenous DKK‑3/REIC inhibits Wnt/β‑catenin signaling and cell proliferation in human kidney cancer KPK1". Oncology Letters 14, no. 5 (2017): 5638-5642. https://doi.org/10.3892/ol.2017.6833
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team